The short version
9 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Nicardipine Hydrochloride
Nicardipine Hydrochloride · NICARDIPINE HYDROCHLORIDE 2.5 mg/mL · Injection, Solution · Intravenous · Qilu Pharmaceutical Co., Ltd.
NDC 67184-0611-02 · 10 VIAL in 1 CARTON / 10 mL in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA219608
- TE code
- AP
- Approval date
- Oct 28, 2025
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Nicardipine Hydrochloride (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Baxter Healthcare Corporation | NICARDIPINE HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Baxter Healthcare Corporation | NICARDIPINE HYDROCHLORIDE .1 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Eugia US LLC | NICARDIPINE HYDROCHLORIDE 25 mg/10mL | Jul 15, 2026 | Sep 3, 2026 |
| American Regent, Inc. | NICARDIPINE HYDROCHLORIDE 2.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Archis Pharma LLC | NICARDIPINE HYDROCHLORIDE 2.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Corporation | NICARDIPINE HYDROCHLORIDE 2.5 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Civica, Inc. | NICARDIPINE HYDROCHLORIDE 2.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc. | NICARDIPINE HYDROCHLORIDE 2.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Qilu Pharmaceutical Co., Ltd. | NICARDIPINE HYDROCHLORIDE 2.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | NICARDIPINE HYDROCHLORIDE 2.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | NICARDIPINE HYDROCHLORIDE .1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | NICARDIPINE HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Nicardipine Hydrochloride — NDC 67184-0611-02," retrieved September 3, 2026, https://drugdashboards.com/drug/67184061102.
Free to cite with attribution — see how the data is put together.